MedTrace Logo

Long Term Follow-up of Pegylated-Interferon Alpha-2b

NCT00146705 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 266

Last updated 2007-08-01

No results posted yet for this study

Summary

The aim of this study was to investigate the long term outcome of Peginterferon alpha-2b with or without the addition of lamivudine in patients with chronic hepatitis B

Conditions

Interventions

PROCEDURE

blood samples are taken once

Sponsors & Collaborators

  • Foundation for Liver Research

    lead OTHER

Principal Investigators

  • Harry LA Janssen, MD PhD · Department of Gastroenterology and Hepatology, University Medical Center Rotterdam, Rotterdam, the Netherlands

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Completion
2006-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00146705 on ClinicalTrials.gov